FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

TULLIS DICKERSON CAPITAL FOCUS III, L.P.
2. Issuer Name and Ticker or Trading Symbol

EXAGEN INC. [ XGN ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    __X__ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle)

11770 US HIGHWAY ONE, SUITE 503
3. Date of Earliest Transaction (MM/DD/YYYY)

3/20/2020
(Street)

PALM BEACH GARDENS, FL 33408
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 3/20/2020  J(1)  164420 (1)D$0.00 1625165 I See footnote (2)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares

Explanation of Responses:
(1) Tullis and Tullis Growth, respectively, (as each is defined in Footnote (2) below) distributed in the aggregate 164,420 shares of Common Stock of Exagen Inc. to their respective non-affiliate limited partners on a pro rata basis, for no consideration.
(2) The shares reported on this form are held of record by Tullis-Dickerson Capital Focus III, L.P. ("Tullis"), Tullis Growth Fund, L.P. ("Tullis Growth") and Tullis Growth Fund II, L.P. ("Tullis Growth II"). Tullis-Dickerson Partners III, LLC ("Tullis Partners") is the general partner of Tullis and may be deemed to beneficially own the securities held by Tullis. Tullis Growth Partners, LLC and Tullis Growth Partners II, LLC are the general partners of Tullis Growth and Tullis Growth II, respectively, and may be deemed to beneficially own the securities held by Tullis Growth and Tullis Growth II. James L.L. Tullis is a Principal of each of the foregoing entities and may be deemed to possess voting and investment control over, and may be deemed to have an indirect beneficial ownership with respect to, the shares held by Tullis, Tullis Growth and Tullis Growth II.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
TULLIS DICKERSON CAPITAL FOCUS III, L.P.
11770 US HIGHWAY ONE, SUITE 503
PALM BEACH GARDENS, FL 33408

X

Tullis Growth Fund, L.P.
11770 US HIGHWAY ONE, SUITE 503
PALM BEACH GARDENS, FL 33408

X

TULLIS GROWTH FUND II, L.P.
11770 US HIGHWAY ONE, SUITE 503
PALM BEACH GARDENS, FL 33408

X

TULLIS DICKERSON PARTNERS III, L.L.C.
11770 US HIGHWAY ONE, SUITE 503
PALM BEACH GARDENS, FL 33408

X


Signatures
Tullis-Dickerson Capital Focus III, L.P., By: Tullis-Dickerson Partners, L.L.C., its general partner, /s/ James L. L. Tullis, Name: James L.L. Tullis, Title: Manager3/24/2020
**Signature of Reporting PersonDate

Tullis Growth Fund, L.P., By: Tullis-Growth Partners, L.L.C., its general partner, /s/ James L. L. Tullis, Name: James L.L. Tullis, Title: Manager3/24/2020
**Signature of Reporting PersonDate

Tullis Growth Fund II, L.P., By: Tullis-Growth Partners II, L.L.C., its general partner, /s/ James L. L. Tullis, Name: James L.L. Tullis, Title: Manager3/24/2020
**Signature of Reporting PersonDate

Tullis-Dickerson Partners III, L.L.C., /s/ James L. L. Tullis, Name: James L.L. Tullis, Title: Manager3/24/2020
**Signature of Reporting PersonDate

Exagen (NASDAQ:XGN)
Historical Stock Chart
From Apr 2020 to May 2020 Click Here for more Exagen Charts.
Exagen (NASDAQ:XGN)
Historical Stock Chart
From May 2019 to May 2020 Click Here for more Exagen Charts.